Skip to main content
. 2021 Jan 22;16(1):e0245924. doi: 10.1371/journal.pone.0245924

Fig 7. SAP attenuates ORN06-increased extracellular IL-6 from human PBMC.

Fig 7

(A) Quantification of extracellular IL-6 accumulation post ORN06 treatment at 0–1 μg/mL and 10 ng/ml M-CSF. (B) Quantification of extracellular IL-6 levels for control, ORN06 and then buffer, and ORN06 and then SAP-treated human PBMC cultured in presence of 10 ng/ml M-CSF. Values are mean ± SEM, n = 6 (human PBMC from 3 males and 3 females). * p < 0.05 (1-way ANOVA, Bonferroni’s test).